ResMed Inc. (RSMDF)
OTCMKTS · Delayed Price · Currency is USD
26.73
0.00 (0.00%)
Jan 5, 2026, 9:30 AM EST
ResMed Market Cap
ResMed has a market cap or net worth of $36.3 billion as of January 7, 2026. Its market cap has increased by 7.37% in one year.
Market Cap
36.30B
Enterprise Value
35.76B
Revenue
5.26B
Ranking
n/a
PE Ratio
25.24
Stock Price
$26.73
Market Cap Chart
Since June 2, 1995, ResMed's market cap has increased from 38.59M to 36.30B, an increase of 93,953.17%. That is a compound annual growth rate of 25.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 36.30B | 3.39% |
| Dec 31, 2025 | 35.11B | 4.54% |
| Dec 31, 2024 | 33.58B | 32.73% |
| Dec 29, 2023 | 25.30B | -17.24% |
| Dec 30, 2022 | 30.57B | -19.72% |
| Dec 31, 2021 | 38.08B | 23.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 726.40M |
| Elite Pharmaceuticals | 516.25M |
| Northwest Biotherapeutics | 444.91M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 270.65M |